Compare Amazon.com Inc (AMZN) vs BioNano Genomics Inc (BNGO) Price & Performance

Amazon (AMZN) trades at $245.34, down 0.69% over the past day, with a bullish technical outlook supported by moving averages and strong support at $241. The company reported robust fundamentals with 2025 revenue of $716.92B and net income of $77.67B, reflecting a 10.83% margin. Recent Q1 2026 earnings beat expectations with EPS of $2.78 vs. $1.63 expected. Operating cash flow reached $139.51B in 2025, though heavy investing outflows continue for growth initiatives.

Outlook remains positive with 88.3% analyst buy ratings and a $320.75 consensus price target, implying significant upside. Key risks include intense competition in retail and cloud, high valuation multiples, and macroeconomic sensitivity. Growth drivers include AWS expansion and AI investments, but execution on capex and margin sustainability are critical for continued shareholder value.

BNGO trades at $1.20, up 5.26% today, but technical signals are bearish with moving averages indicating selling pressure. The company reported a net loss of -$26.40M in 2025 despite beating EPS estimates in recent quarters. Recent news highlights leadership changes and growing adoption of its optical genome mapping technology, with 67% year-over-year growth in studies presented at ESHG 2026 (GlobeNewswire, June 18, 2026).

The outlook remains challenged by persistent losses and negative cash flow, though low valuation ratios (P/S 0.31, P/B 0.37) may attract value investors. Analyst sentiment is cautiously optimistic with 57% buy ratings, but execution risks and profitability concerns pose significant headwinds for near-term stock performance.